IS4848A - Pharmaceutically useful compounds - Google Patents

Pharmaceutically useful compounds

Info

Publication number
IS4848A
IS4848A IS4848A IS4848A IS4848A IS 4848 A IS4848 A IS 4848A IS 4848 A IS4848 A IS 4848A IS 4848 A IS4848 A IS 4848A IS 4848 A IS4848 A IS 4848A
Authority
IS
Iceland
Prior art keywords
pharmaceutically useful
useful compounds
compounds
pharmaceutically
useful
Prior art date
Application number
IS4848A
Other languages
Icelandic (is)
Inventor
Bantick John
Bonnert Roger
Cage Peter
Donald David
Furber Mark
Hirst Simon
Perry Matthew
Phillips Eifron
Original Assignee
Astra Pharmaceuticals Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9605803.7A external-priority patent/GB9605803D0/en
Priority claimed from GBGB9610474.0A external-priority patent/GB9610474D0/en
Priority claimed from GBGB9610894.9A external-priority patent/GB9610894D0/en
Priority claimed from GBGB9700862.7A external-priority patent/GB9700862D0/en
Application filed by Astra Pharmaceuticals Ltd. filed Critical Astra Pharmaceuticals Ltd.
Publication of IS4848A publication Critical patent/IS4848A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS4848A 1996-03-20 1998-09-16 Pharmaceutically useful compounds IS4848A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9605803.7A GB9605803D0 (en) 1996-03-20 1996-03-20 Pharmaceutically-active compound
GBGB9610474.0A GB9610474D0 (en) 1996-05-18 1996-05-18 Pharmaceutically active compounds
GBGB9610894.9A GB9610894D0 (en) 1996-05-24 1996-05-24 Pharmaceutically useful compounds
GBGB9700862.7A GB9700862D0 (en) 1997-01-16 1997-01-16 Pharmaceutically useful compounds
PCT/SE1997/000471 WO1997034893A1 (en) 1996-03-20 1997-03-20 Pharmaceutically useful compounds

Publications (1)

Publication Number Publication Date
IS4848A true IS4848A (en) 1998-09-16

Family

ID=27451427

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4848A IS4848A (en) 1996-03-20 1998-09-16 Pharmaceutically useful compounds

Country Status (19)

Country Link
EP (1) EP0888347A1 (en)
JP (1) JP2000506884A (en)
KR (1) KR20000064716A (en)
CN (1) CN1218472A (en)
AR (1) AR006520A1 (en)
AU (1) AU712141B2 (en)
BR (1) BR9708103A (en)
CA (1) CA2247814A1 (en)
CZ (1) CZ297798A3 (en)
EE (1) EE9800298A (en)
ID (1) ID16283A (en)
IL (1) IL126271A0 (en)
IS (1) IS4848A (en)
NO (1) NO984290L (en)
NZ (1) NZ331614A (en)
PL (1) PL328921A1 (en)
SK (1) SK118798A3 (en)
TR (1) TR199801861T2 (en)
WO (1) WO1997034893A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10110749A1 (en) * 2001-03-07 2002-09-12 Bayer Ag Substituted aminodicarboxylic acid derivatives
JP2003002863A (en) * 2001-06-25 2003-01-08 Nippon Soda Co Ltd Method for producing benzoic acids and novel compounds
SE0102404D0 (en) * 2001-07-04 2001-07-04 Active Biotech Ab Novel immunomodulating compounds
US6642249B2 (en) 2001-07-04 2003-11-04 Active Biotech Ab Immunomodulating compounds
DE10229762A1 (en) * 2002-07-03 2004-01-22 Aventis Pharma Deutschland Gmbh Pyrazoloisoquinoline derivatives for the inhibition of NFkappaB-inducing kinase
WO2004048378A1 (en) 2002-11-22 2004-06-10 Active Biotech Ab Pyrazoloquinolines with immunomodulating activity
EP1572689B1 (en) * 2002-12-16 2009-03-11 Active Biotech AB Tetracyclic immunomodulatory compounds
BRPI0408365B8 (en) 2003-03-14 2021-05-25 Avidex Ltd heterocyclic immunomodulating compounds
GB0325644D0 (en) 2003-11-04 2003-12-10 Avidex Ltd Immuno ihibitory pyrazolone compounds
AU2004298486A1 (en) 2003-12-12 2005-06-30 Wyeth Quinolines useful in treating cardiovascular disease
FR2870239B1 (en) * 2004-05-11 2006-06-16 Sanofi Synthelabo DERIVATIVES OF 2H- OR 3H-BENZO [E] INDAZOL-1-YLE CARBAMATE, THEIR PREPARATION AND THEIR THERAPEUTIC USE.
GB0411770D0 (en) * 2004-05-26 2004-06-30 Avidex Ltd Immuno inhibitory heterocyclic compouds
CN1997645B (en) * 2004-08-09 2012-05-23 麦迪金股份公司 Immunomodulatory Oxypyrazolocinnolines as CD80 Inhibitors
DK2089367T3 (en) 2006-10-31 2012-02-06 Pfizer Prod Inc Pyrazoline compounds as mineralocorticoid receptor antagonists
CN102372710A (en) * 2010-08-18 2012-03-14 山东轩竹医药科技有限公司 Fused cyclic compound being taken as mineral corticoid recept antagonist
BR112013020282A2 (en) 2011-02-09 2017-07-18 Nissan Chemical Ind Ltd pyrazole derivative and control agent
CN112654396B (en) * 2018-09-07 2025-07-01 默克专利股份公司 5-Morpholin-4-yl-pyrazolo[4,3-b]pyridine derivatives
WO2021257863A1 (en) 2020-06-19 2021-12-23 Incyte Corporation Pyrrolotriazine compounds as jak2 v617f inhibitors
US11691971B2 (en) 2020-06-19 2023-07-04 Incyte Corporation Naphthyridinone compounds as JAK2 V617F inhibitors
CR20230057A (en) 2020-07-02 2023-08-15 Incyte Corp Tricyclic urea compounds as jak2 v617f inhibitors
US11767323B2 (en) 2020-07-02 2023-09-26 Incyte Corporation Tricyclic pyridone compounds as JAK2 V617F inhibitors
US11661422B2 (en) 2020-08-27 2023-05-30 Incyte Corporation Tricyclic urea compounds as JAK2 V617F inhibitors
US11919908B2 (en) 2020-12-21 2024-03-05 Incyte Corporation Substituted pyrrolo[2,3-d]pyrimidine compounds as JAK2 V617F inhibitors
AR125273A1 (en) 2021-02-25 2023-07-05 Incyte Corp SPIROCYCLIC LACTAMS AS JAK2 INHIBITORS V617F
AU2023235313A1 (en) 2022-03-17 2024-10-03 Incyte Corporation Tricyclic urea compounds as jak2 v617f inhibitors
CN119638634B (en) * 2023-09-18 2026-01-30 上海赛默罗生物科技有限公司 2-oxo-coral compounds, their preparation methods and uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524146A (en) * 1982-12-08 1985-06-18 Ciba-Geigy Corporation Certain -2-heterocycle substituted pyrazoloquinolines
JPS61112075A (en) * 1984-11-05 1986-05-30 Shionogi & Co Ltd Thienylpyrazoloquinoline derivative
SE8903564D0 (en) * 1989-10-26 1989-10-26 Pharmacia Ab NEW USE CONDENSED QUINOLINE COMPOUND
JPH05194515A (en) * 1991-07-31 1993-08-03 Kyowa Hakko Kogyo Co Ltd Condensed naphthyridine derivative

Also Published As

Publication number Publication date
CZ297798A3 (en) 1999-03-17
AU712141B2 (en) 1999-10-28
NO984290L (en) 1998-10-27
NZ331614A (en) 2000-07-28
ID16283A (en) 1997-09-18
JP2000506884A (en) 2000-06-06
TR199801861T2 (en) 1998-12-21
SK118798A3 (en) 1999-03-12
AR006520A1 (en) 1999-09-08
AU2186797A (en) 1997-10-10
BR9708103A (en) 1999-07-27
CN1218472A (en) 1999-06-02
NO984290D0 (en) 1998-09-16
CA2247814A1 (en) 1997-09-25
EE9800298A (en) 1999-02-15
IL126271A0 (en) 1999-05-09
PL328921A1 (en) 1999-03-01
EP0888347A1 (en) 1999-01-07
KR20000064716A (en) 2000-11-06
WO1997034893A1 (en) 1997-09-25

Similar Documents

Publication Publication Date Title
ID19609A (en) HETEROSICLIC COMPOUNDS
ID19403A (en) HETEROSICLIC COMPOUNDS
ID16152A (en) TRIARIL COMPOUNDS
EE9800298A (en) Pharmaceutically useful compounds
ID15904A (en) TIOFENOPIRIMIDINE COMPOUNDS
ID19430A (en) COMPOUND HETEROSICLIC COMPOUND
BR9709230A (en) Compound
BR9710352A (en) Pyridylpyrrole compounds
BR9707051A (en) Compound
DE69716924D1 (en) Phosphonate-NUCLEOTIDE COMPOUNDS
ID18685A (en) SUBSTITUTED TRISICLIC COMPOUNDS
ID19075A (en) CAPACIC PLACES FOR ASETALDEHIDA
EE9800430A (en) New compounds
BR9705635A (en) Compounds
FI972853A0 (en) Viedeoneuvottelulaitteisto
NO983090D0 (en) Therapeutic compounds
BR9711205A (en) Compound
DK0923594T3 (en) Bromothiacumicin compounds
FI962420A0 (en) Foerstaerkare med laogbrus
DE69709659D1 (en) HALOPROPARGYL-INCLUSION COMPOUNDS
IS4932A (en) New compounds
NO964439D0 (en) For
SE9603300D0 (en) Compounds
ID17103A (en) SULFONAMIDA COMPOUNDS
SE9600275D0 (en) Compounds